IEEE has announced an initiative to use technologies such as artificial intelligence (AI), blockchain and distributed ledger technologies (DLT), and the internet of things (IoT) for clinical trials.

The technical professional organisation will also explore sensors and virtual and augmented reality (VR/AR) in combination with existing technology systems for enhancing remote clinical trials, from patient recruitment through to FDA submission.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The IEEE and its Standards Association (IEEE SA) named the initiative ‘Technology and Data Harmonization for Enabling Remote Clinical Trials’.

Participants in the initiative are required to develop a consensus-driven workflow that will later be tested against a simulated clinical trial.

Through the initiative, IEEE seeks to maintain efficient and inclusive patient engagement, data integrity, a single original and immutable patient log and decreased time and costs.

The organisation will set up an assimilated forum to assess and test the best methods for achieving data outputs and capabilities that support clinical trials.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The initiative’s chairman Tory Cenaj said: “The estimated $44.2 billion global clinical trials market is facing a number of challenges related to patient recruitment and retention, rising costs to meet regulatory policies, data governance, and more.

“This important project establishes a framework for vastly improving how remote patient clinical trials are conducted by leveraging new technologies to significantly reduce the time and cost of bringing life-saving medicines to market.”

The IEEE SA develops consensus standards via an open process that engages industry and brings together a broad stakeholder community.

It has a portfolio of more than 1,250 active standards and over 700 standards under development.